Ozempic® providers &
prescriptions in Tupelo, MS
Verified Ozempic providers in Tupelo, MS. Checked against the NPI registry, never ranked by who pays us.[7]
Find an Ozempic provider in Mississippi.
Every entry is checked against the federal NPI registry. We do not accept payment for placement.
How to get Ozempic in Tupelo.
30 GLP-1 prescribers and 6 local resource types are on record for Tupelo, plus 3 nearby towns in the directory.
Medicaid status above is for weight-loss use and was compiled April 2026 from KFF and public Medicaid trackers; only 13 states cover it and several are mid-change, so confirm Mississippi’s current Medicaid and plan rules before booking. GLPHelper provides information and provider matching, not medical or coverage advice.
An injectable medication for adults with type 2 diabetes, and, by indirect effect, for body weight.
Ozempic is the brand name for semaglutide, a once-weekly subcutaneous injection in the GLP-1 receptor agonist class. It mimics a gut hormone that signals satiety to the brain and slows gastric emptying. In randomized trials it lowered HbA1c by 1.4 to 1.8 percentage points and produced a mean weight loss of 4.5 to 6.4 kg at the 1 mg dose.[2][3]
It is FDA-approved for glycemic control in adults with type 2 diabetes mellitus and for reducing the risk of major cardiovascular events in adults with T2D and established cardiovascular disease. The same molecule, marketed by the same manufacturer as Wegovy, is the FDA-approved formulation for chronic weight management.[1]
For the receptor story in plain English, read how does ozempic work.
Rapid weight loss can change the midface. The mechanism people call ozempic face is in the research notes.
Community health · CDC
Weight & metabolic health in Tupelo
Tupelo, Mississippi has a population of 37,923 people. The adult obesity rate in Tupelo is an age-adjusted estimate of 36.3%, 4.1 percentage points below the Mississippi state rate of 40.4%. Diagnosed diabetes reaches 12.4% of adults in Tupelo. Inactivity, meaning no leisure-time physical activity reported in the past month, affects 30.7% of adults in Tupelo.
- of Tupelo adults have obesity
- 36.3%
- diagnosed diabetes
- 12.4%
- no regular physical activity
- 30.7%
Age-adjusted estimates for Tupelo, community figures, not individual risk. CDC PLACES, 2025 release.
The prescription is one part. Here is the rest, in Tupelo.
Trials of semaglutide paired the drug with diet counseling and regular activity. Every name below is a real listing near Tupelo, MS, ordered as the registry lists them, never by who pays us.
Nutritionists
A nutritionist helps you get enough protein and fiber while the medication cuts your appetite. Call to ask what they cover.
Gyms near you
A gym gives you the regular movement that keeps muscle while the weight comes off.
What the trials actually showed.
We summarize results from the SUSTAIN program, the seven Phase III randomized trials Novo Nordisk submitted to the FDA, and the SUSTAIN-6 cardiovascular outcomes trial. Numbers below are means at the 30-week endpoint, 1 mg weekly dose.
Most side effects are gastrointestinal and resolve within weeks.
The most common adverse events in SUSTAIN trials were nausea (15 to 20%), diarrhea (8 to 9%), and vomiting (5 to 9%), all dose-dependent and typically transient.[1] Serious events were rare but include pancreatitis, gallbladder disease, and an FDA boxed warning regarding thyroid C-cell tumors based on rodent data.[8]
Most directories hide the price. We don't.
Cash prices vary roughly 50× between the brand-name retail rate and a manufacturer savings card. The number you actually pay depends on your insurance plan, your diagnosis code, and which pharmacy fills the script. Here are the ranges, plainly.
Data sources: GoodRx national retail survey[6], CMS Part D formulary files[5], Novo Nordisk patient access program.
NPI-verified Ozempic (semaglutide) prescribers and clinics, never ranked by who pays us.
Find NPI-verified Ozempic (semaglutide) doctors, clinics, and pharmacies in the states we cover, never ranked by who pays us.
The questions people ask before they book.
Answers reviewed by the GLPHelper Medical Team. Citations link to primary sources, never marketing copy.
Yes. Semaglutide is a federally scheduled prescription drug in all 50 states. A licensed prescriber (MD, DO, NP, or PA) must evaluate you before issuing a prescription. No state permits pharmacist-initiated prescribing of GLP-1s.[1]